References
- Borah M F, Schoenfeld P Y, Gotch F A, Sargent J A, Wolfson M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14: 491–500
- Wolfson M, Jones M R, Kopple J. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982; 21: 500–506
- Ward R A, Shirlow M J, Hayes J M, Chapman G V, Farrell PC. Protein catabolism during hemodialysis. Am J Clin Nutr 1979; 32: 2443–2449
- Gutierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487–494
- Gutierrez A, Bergstr Sm J, Alvestrand A. Protein catabolism in sham-hemodialysis: the effect of different membranes. Clin Nephrol 1992; 38: 20–29
- Urena P, Herbelin A, Zingraff J, Lair M, Man N K, Descamps-Latscha B, Drueke T. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol Dial Transplant 1992; 7: 16–28
- Canivet E, Lavaud S, Wong T, Guenounou M, Willemin J C, Potron G, Chanard J. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 1994; 23: 41–46
- Henderson L W, Koch K M, Dinarello C A, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1983; 1: 3–8
- Lofberg E, Wernerman J, Noree L O, Von der Decken A, Vinnars E. Ribosome and free amino acid content in muscle during hemodialysis. Kidney Int 1991; 39: 984–989
- Lim V S, Bier D M, Flanigan M, Sum Ping ST. The effect of hemodialysis on protein metabolism. J Am Soc Nephrol 1990; 1: 366
- Dinarello CA. Agents provocateurs in hemodialysis?. Kidney Int 1992; 41: 683–694
- Haeffner-Cavaillon N, Cavaillon J M, Laude M, Kazachtkine MD. C3a (C3a des Arg) induces production and release of interleukine 1 by cultured human monocytes. J Immunol 1987; 139: 794–799
- Schindler R, Gelfand J A, Dinarello CA. Recombinant C5a stimulates transcription rather than translation of IL-1 and TNF: translational signal provided by LPS or IL-1 itself. Blood 1990; 76: 1631–1638
- Cavaillon J M, Fitting C, Haeffner-Cavaillon N. Recombinant C5a enhances interleukin-1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol 1990; 20: 253–257
- Betz M, Haensch G M, Rauterberg E W, Bommer J, Ritz E. Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 1988; 34: 67–73
- Evans R C, Holmes CJ. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 1991; 9: 92–101
- Aderka D, Engelmann H, Maor Y, Brakesbusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323–329
- Dinarello CA. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int 1992; 42: S68–S77, Suppl 38
- Sunder-Plassmann G, Kapiotis S, Gasche C, Klaar U. Functional characterization of cytokine autoantibodies in chronic renal failure patients. Kidney lnt 1994; 45: 1484–1488
- Herbelin A, Nguyen A T, Urena P, Descamps-Latscha B. Induction of cytokines by dialysis membranes in normal whole blood: a new in vitro assay for evaluating membrane biocompatibility. Blood Purif 1992; 10: 40–52
- Mault J R, Kresowick T F, Dechert R E, Arnoldi D K, Swartz R D, Bartlett RH. CAVH: The answer to starvation in acute renal failure. Trans Am Soc Artif Org 1984; 30: 203–206
- Chima C S, Meyer L, Hummell A C, Bosworth C, Heyka R, Paganini E P, Werynski A. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993; 3: 1516–1521
- Clark W R, Mueller B A, Alaka K J, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413–1420
- Van Bommel E FH, Bouvy N D, So K L, Zietse R, Vincent H H, Braining H A, Weimar W. Acute dialytic support for the critically ill. intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 1995; 15: 192–200
- Bellomo R, Farmer M, Wright C, Parkin G, Boyce N. Treatment of sepsis-associated severe acute renal failure with continuous hemodiafiltration: clinical experience and comparison with conventional dialysis. Blood Purif 1995; 13: 246–254
- Manns M, Siegler M H, Teehan B P, Dixit K. Renal function changes during intermittent hemodialysis (IHD) in critically ill patients with acute renal failure (ARF). Blood Purif 1994; 12: 188, abstract
- Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993; 3: 187–198
- Storck M, Haiti W H, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991; 337: 452–455
- Gotloib L, Barzilay E, Shustak A, Lev A. Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: preliminary report. Crit Care Med 1984; 12: 997–1000
- Coraim F, Wolner E. Management of cardiac surgery patients with continuous arteriovenous hemofiltration. Continuous Arteriovenous Hemofiltration (CAVH) International Conference on CAVH, Aachen, FRG, November 2–3, HG Siebarth, H Mann. Karger, BaselSwitzerland 1985; 103–110
- Coraim F, Fasol R, Stellwag F, Wolner E. Continuous arteriovenous hemofiltration (CAVH) after cardiac surgery. Continuous Arteriovenous Hemofiltration (CAVH), HG Sieberth, H Mann. Karger, BaselSwitzerland 1985; 116–124, International Conference on CAVH, Aachen, FRG, November 2–3,1984
- Ossenkoppele G J, van der Meulen J, Bronsveld W, Thijs LG. Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 1985; 13: 102–104
- Radzivil G G, Beloborodov V B, Broniakin IuV, Roslyi I M, Gracheva AM. Hemosorption as a method of treating endotoxicosis in patients with septic shock of meningococcal etiology. Anesteziol Reanimatol 1987; 2: 46–50
- Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A. Hemofiltration in septic ARDS. the artificial kidney as an artificial endocrine lung. Resuscitation 1986; 13: 123–132
- Zobel G, Trop M, Ring E, Grubbauer HM. Arteriovenous hemofiltration in children with multiple organ system failure. Int J Artif Org 1987; 10: 233–238
- Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Zeev IB. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1989; 17: 634–637
- Lee P A, Matson J R, Pryor R W, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914–924
- Bellomo R, Tipping P, Boyce N. Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 1991; 37: M322–M323
- Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522–526
- Elliott D, Wiles C E, Reynolds HN. Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994; 22: 718–719, letter
- Millar A B, Armstrong L, van der Linden J, Moat N, Ekroth R, Westwick J, Scallan M, Lincoln C. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thome Surg 1993; 56: 1499–1502
- Byrick R J, Goldstein M B, Wong PY. Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med 1992; 20: 1483–1486
- Kierdorf HR. Einfluβ der kontinuierlichen Hämofiltration auf Proteinkatabolismus, Mediatorsubstanzen und Prognose des akuten Nierenversagens im Multiorganversagen. Universität Aachen, Habilitationsschrift 1993
- Andreasson S, Gothberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993; 56: 1515–1517
- Mahiout A, Courtney JM. Effect of dialyser membranes on extracellular and intracellular granulocyte and monocyte activation in ex vivo pyrogen-free conditions. Biomaterials 1994; 15: 969–980
- Schetz M. Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994; 4: 715–716, letter
- Beutler B. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock. New Horizons 1993; 1: 3–12
- Böhrer H, Schmidt H, Bach A, Motsch J, Martin E. Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994; 4: 717–718, letter
- Grootendorst A F, Van Bommel E FH. The role of hemofiltration in the critically-ill intensive care unit patient: present and future. Blood Purif 1993; 11: 209–223
- Schiffl H, Lang S M, König A, Strasser T, Haider M C, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344: 570–572
- Hakim R M, Wingard R L, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338–1342
- Himmelfarb J, Lazarus M, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991; 17: 271–278
- Himmelfarb J, Ault K A, Holbrook D, Leeber D A, Hakim RM. Intradialytic granulocyte reactive oxygen species production: a prospective crossover trial. J Am Soc Nephrol 1993; 4: 178–186
- Vanholder R, Ringoir S, Dhondt A, Hakim RM. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320–327
- Cristol J P, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C. Enhancement of reative oxygen sepsices production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant 1994; 9: 389–394
- Himmelfarb J, Hakim RM. Biocompatibility and risk of infection in haemodialysis patients. Nephrol Dial Transplant 1994; 9: 138–144, Suppl 2
- Woodrow G, Turney JH. Cause of death in acute renal failure. Nephrol Dial Transplant 1992; 7: 230–234
- Schulman G, Fogo A, Gung A, Badr K, Hakim R. Complement activation retards resolution of ischemic renal failure in the rat. Kidney Int 1991; 40: 1069–1074
- Homberger J C, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992; 3: 1227–1237
- Tanaka H, Sugimoto H, Yoshioka T, Sugimoto T. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. Ann Surg 1991; 213: 81–85
- Tanaka H, Ogura H, Yokota J, Sugimotot H, Yoshioka T, Sugimotot T. Acceleration of superoxide production from leukocytes in trauma patients. Ann Surg 1991; 214: 187–192
- Nuijens J H, Abbink J J, Wachtfogel Y T, Colman R W, Eerenberg A JM, Dors D, Kamp A JM, Strack van Schijndel R JM, Thijs L G, Hack CE. Plasma elastase α1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119: 159–168
- Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, Chiara O, Agostoni A, Nespoli A. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Arch Surg 1992; 127: 1219–1224
- Bone RC. Inhibitors of complement and neutrophilsa critical evaluation of their role in the treatment of sepsis. Crit Care Med 1992; 20: 891–898
- Dofferhoff A SM, de Jong H J, Bom V JJ, van der Meer J, Limburg P C, Vries- De, Hospers H G, Man-Ink J, Mulder P OM, Weits J. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 1992; 24: 197–204
- Hörl W H, Schaefer R M, Hörl M, Heidland A. Neutrophil activation in acute renal failure and sepsis. Arch Surg 1990; 125: 651–654
- Craddock P R, Hammerschmidt DE. Complement-mediated granulocyte activation and down-regulation during hemodialysis. ASAIO J 1984; 7: 50–56
- Lo S K, Detmers P A, Levin S M, Wright SD. Transient adhesion of neutrophils to endothelium. J Exp Med 1989; 169: 1779–1793
- Himmelfarb J, Gerard N P, Hakim RM. Intradialytic modulation of granulocyte C5a receptors. J Am Soc Nephrol 1991; 2: 920–926
- Haag-Weber M, Horl WH. Can the hypercatabolic state in acute renal failure be modified by treatment?. International Yearbook of Nephrology, VE Andreucci, LG Fine. Nephrol Dial Transplant. 1994; 9: 105–109, Suppl